Cytokinetics, Inc. Reports First Quarter 2016 Financial Results

April 28, 2016 (GLOBE NEWSWIRE) -- Cytokinetics, Inc. (Nasdaq:CYTK) reported total research and development revenues ... the Safety and Efficacy of Tirasemtiv in Patients with Amyotrophic Lateral Sclerosis,” published in Amyotrophic Lateral Sclerosis ...